Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (4): 139-148.doi: 10.6040/j.issn.1673-3770.0.2022.181

Previous Articles    

Long-term progress of visual field defect for open-angle glaucoma patients with ab interno trabeculotomy with the trabectome

MENG Sukun1,2, ZHANG Chun1,2   

  1. 1. Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China2. Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China
  • Published:2023-07-27

PDF (PC)

158

Abstract: Objective To observe the long-term efficacy of ab interno trabeculotomy with the Trabectome and the progress of visual field defect for open-angle glaucoma patients. Methods In this retrospective cohort study, 62 primary open-angle glaucoma patients who underwent ab interno trabeculotomy with the Trabectome were included. The main outcome measure was visual field, and the secondary outcome measures included intraocular pressure, the amount of glaucoma medications, and surgical complications. The Wilcoxon test was used to compare the postoperative intraocular pressure and the number of glaucoma medications with baselines. The Enhanced Glaucoma Staging System(GSS 2)was used to evaluate the severity of preoperative visual field defects and to stage the preoperative visual field. The parameters of diffuse visual field defect(mean defect of Octopus visual field test and mean deviation of Humphrey visual field test)in all follow-ups were analyzed by linear regression with time. Whether the visual field defect progressed or not was judged according to the slope of regression equation. Moreover, the risk factors of visual field defect progression were further explored. Results The preoperative intraocular pressure of all 62 cases was(20.9±7.5)mmHg and the preoperative number of glaucoma medications before was(2.6±1.2)species. After operation, intraocular pressure decreased to(17.6±3.4)mmHg(P=0.018)and the number of glaucoma medications decreased to(2.3±1.1)species(P=0.317)at 5 years. Fourteen cases(22.6%)experienced progression of visual field defects. There were differences in the history of diabetes and preoperative visual field staging between the two groups. The proportion of progressive cases in cases with diabetes was 46.2% compared to 16.3% in cases without diabetes(P=0.022). The percentage of progression of visual field defect was 38.9% in cases with mild preoperative visual field staging(stages 0-3)and 15.9% in cases with severe preoperative visual field staging(stages 4-5)(P=0.049). Conclusion Ab interno trabeculotomy with the Trabectome had a definite long-term efficacy. Some patients still had visual field defects progression after operation. Visual functional impairment of glaucoma should be considered during postoperative follow-up. Patients with diabetes and mild preoperative visual field stage were more likely to have visual field defects progression. The follow-up frequency of these patients should be increased and their visual field should be frequently monitored.

Key words: Ab interno trabeculotomy, Open-angle glaucoma, Visual field, Minimally invasive glaucoma surgeries, Risk factor

CLC Number: 

  • R775
[1] Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis[J]. Ophthalmology, 2014, 121(11): 2081-2090. doi:10.1016/j.ophtha.2014.05.013
[2] Song PG, Wang JW, Bucan K, et al. National and subnational prevalence and burden of glaucoma in China: a systematic analysis[J]. J Glob Health, 2017, 7(2): 020705. doi:10.7189/jogh.07.020705
[3] Avar M, Jordan JF, Neuburger M, et al. Long-term follow-up of intraocular pressure and pressure-lowering medication in patients after ab-interno trabeculectomy with the Trabectome[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(5): 997-1003. doi:10.1007/s00417-019-04259-5
[4] Dang YL, Cen YJ, Hong Y, et al. Safety and efficiency of trabectome-mediated trabecular meshwork ablation for Chinese Glaucoma patients: a two-year, retrospective, multicentre study[J]. Chin Med J(Engl), 2018, 131(4): 420-425. doi:10.4103/0366-6999.225050
[5] Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the tube versus trabeculectomy(TVT)study during five years of follow-up[J]. Am J Ophthalmol, 2012, 153(5): 804-814.e1. doi:10.1016/j.ajo.2011.10.024
[6] Kwong A, Law SK, Kule RR, et al. Long-term outcomes of resident- versus attending-performed primary trabeculectomy with mitomycin C in a United States residency program[J]. Am J Ophthalmol, 2014, 157(6): 1190-1201. doi:10.1016/j.ajo.2014.02.028
[7] Gedde SJ, Feuer WJ, Lim KS, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 5 years of follow-up[J]. Ophthalmology, 2022, 129(12): 1344-1356. doi:10.1016/j.ophtha.2022.07.003
[8] 王越, 柯敏, 韩芳芳, 等. EX-PRESS引流器植入术与小梁切除术治疗开角型青光眼有效性和安全性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 104-111. doi:10.6040/j.issn.1673-3770.0.2016.230 WANG Yue, KE Min, HAN Fangfang, et al. Efficacy and safety of EX-PRESS implanation versus trabeculectomy for open-angle glaucoma: a meta-analysis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(2): 104-111. doi:10.6040/j.issn.1673-3770.0.2016.230
[9] Saheb H, Ahmed IIK. Micro-invasive glaucoma surgery: current perspectives and future directions[J]. Curr Opin Ophthalmol, 2012, 23(2): 96-104. doi:10.1097/ICU.0b013e32834ff1e7
[10] Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma[J]. Clin Exp Ophthalmol, 2017, 45(4): 393-400. doi:10.1111/ceo.12888
[11] Minckler DS, Baerveldt G, Alfaro MR, et al. Clinical results with the trabectome for treatment of open-angle Glaucoma[J]. Ophthalmology, 2005, 112(6): 962-967. doi:10.1016/j.ophtha.2004.12.043
[12] 黄萍, 王怀洲, 吴慧娟, 等. 小梁消融术疗效和安全性的临床观察[J]. 中华眼科杂志, 2015, 51(2): 115-119. doi:10.3760/cma.j.issn.0412-4081.2015.02.011 HUANG Ping, WANG Huaizhou, WU Huijuan, et al. Preliminary investigation on the safety and efficacy of Trabectome[J]. Journal of Command and Control, 2015, 51(2): 115-119. doi:10.3760/cma.j.issn.0412-4081.2015.02.011
[13] Kaplowitz K, Bussel II, Honkanen R, et al. Review and meta-analysis of ab-interno trabeculectomy outcomes[J]. Br J Ophthalmol, 2016, 100(5): 594-600. doi:10.1136/bjophthalmol-2015-307131
[14] Mosaed S. The first decade of global trabectome outcomes[J]. Eur Ophthalmic Rev, 2014, 8(2): 113. doi:10.17925/eor.2014.08.02.113
[15] Esfandiari H, Shah P, Torkian P, et al. Five-year clinical outcomes of combined phacoemulsification and trabectome surgery at a single glaucoma center[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(2): 357-362. doi:10.1007/s00417-018-4146-y
[16] Brusini P, Filacorda S. Enhanced Glaucoma Staging System(GSS 2)for classifying functional damage in Glaucoma[J]. J Glaucoma, 2006, 15(1): 40-46. doi:10.1097/01.ijg.0000195932.48288.97
[17] Yokoyama Y, Maruyama K, Konno H, et al. Characteristics of patients with primary open angle glaucoma and normal tension glaucoma at a university hospital: a cross-sectional retrospective study[J]. BMC Res Notes, 2015, 8(1): 360. doi:10.1186/s13104-015-1339-x
[18] Minckler D, Mosaed S, Dustin L, et al. Trabectome(trabeculectomy-internal approach): additional experience and extended follow-up[J]. Trans Am Ophthalmol Soc, 2008, 106: 149-159;discussion 159-160
[19] Ahuja Y, Ma Khin Pyi S, Malihi M, et al. Clinical results of ab interno trabeculotomy using the trabectome for open-angle Glaucoma: the mayo clinic series in Rochester, Minnesota[J]. Am J Ophthalmol, 2013, 156(5): 927-935.e2. doi:10.1016/j.ajo.2013.06.001
[20] Pahlitzsch M, Davids AM, Zorn M, et al. Three-year results of ab interno trabeculectomy(Trabectome): Berlin study group[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256(3): 611-619. doi:10.1007/s00417-017-3882-8
[21] Polat JK, Loewen NA. Combined phacoemulsification and trabectome for treatment of glaucoma[J]. Surv Ophthalmol, 2017, 62(5): 698-705. doi:10.1016/j.survophthal.2016.03.012
[22] Dang YL, Wang X, Dai WW, et al. Two-year outcomes of ab interno trabeculectomy with the Trabectome for Chinese primary open angle glaucoma: a retrospective multicenter study[J]. Int J Ophthalmol, 2018, 11(6): 945-950. doi:10.18240/ijo.2018.06.08
[23] Francis BA, Minckler D, Dustin L, et al. Combined cataract extraction and trabeculotomy by the internal approach for coexisting cataract and open-angle glaucoma: initial results[J]. J Cataract Refract Surg, 2008, 34(7): 1096-1103. doi:10.1016/j.jcrs.2008.03.032
[24] Bussel II, Kaplowitz K, Schuman JS, et al. Outcomes of ab interno trabeculectomy with the trabectome by degree of angle opening[J]. Br J Ophthalmol, 2015, 99(7): 914-919. doi:10.1136/bjophthalmol-2014-305577
[25] Jordan JF, Wecker T, van Oterendorp C, et al. Trabectome surgery for primary and secondary open angle glaucomas[J]. Graefes Arch Clin Exp Ophthalmol, 2013, 251(12): 2753-2760. doi:10.1007/s00417-013-2500-7
[26] Lee JWY, Yick DWF, Tsang S, et al. Efficacy and safety of trabectome surgery in Chinese open-angle Glaucoma[J]. Medicine, 2016, 95(15): e3212. doi:10.1097/MD.0000000000003212
[27] 王怀洲, 石砚, 洪洁, 等. 小梁消融术治疗开角型青光眼的初步结果[J]. 眼科, 2014, 23(1): 13-18. doi:10.13281/j.cnki.issn.1004-4469.2014.01.005 WANG Huaizhou, SHI Yan, HONG Jie, et al. The preliminary study on effectiveness and safety of trabectome surgery for open angle glaucoma[J]. Ophthalmology in China, 2014, 23(1): 13-18. doi:10.13281/j.cnki.issn.1004-4469.2014.01.005
[28] 吴慧娟, 侯宪如, 梁勇, 等. 小梁消融术治疗开角型青光眼的长期随访观察[J]. 中国实用眼科杂志, 2016, 34(12): 1323-1327. doi:10.3760/cma.j.issn.1006-4443.2016.12.023 WU Huijuan, HOU Xianru, LIANG Yong, et al. Long-term outcomes of trabectome in the treatment of open angle Glaucoma[J]. Chinese Journal of Practical Ophthalmology, 2016, 34(12): 1323-1327. doi:10.3760/cma.j.issn.1006-4443.2016.12.023
[29] 阿依努·努拉厚, 郭宁, 高云仙, 等. 不同手术方式对原发性开角型青光眼合并白内障患者的影响[J]. 国际眼科杂志, 2018, 18(10): 1902-1905. doi:10.3980/j.issn.1672-5123.2018.10.36
[30] 李雪, 惠玲, 刘霞. 外路小梁切开术与小梁消融术治疗开角型青光眼的临床效果[J]. 临床医学研究与实践, 2019, 4(15): 84-85. doi:10.19347/j.cnki.2096-1413.201915032 LI Xue, HUI Ling, LIU Xia. Clinical effects of external trabeculotomy and trabectome in the treatment of open angle glaucoma[J]. Clinical Research and Practice, 2019, 4(15): 84-85. doi:10.19347/j.cnki.2096-1413.201915032
[31] Kono Y, Kasahara M, Hirasawa K, et al. Long-term clinical results of trabectome surgery in patients with open-angle glaucoma[J]. Graefes Arch Clin Exp Ophthalmol, 2020, 258(11): 2467-2476. doi:10.1007/s00417-020-04897-0
[32] Carreon T, van der Merwe E, Fellman RL, et al. Aqueous outflow - A continuum from trabecular meshwork to episcleral veins[J]. Prog Retin Eye Res, 2017, 57: 108-133. doi:10.1016/j.preteyeres.2016.12.004
[33] 刘瑞宝, 赵颖, 郭明璐, 等. 自噬及其在青光眼中的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 158-161. doi:10.6040/j.issn.1673-3770.0.2018.606 LIU Ruibao, ZHAO Ying, GUO Minglu, et al. Autophagy and its research progress in glaucoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 158-161. doi:10.6040/j.issn.1673-3770.0.2018.606
[34] Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study[J]. Ophthalmology, 2004, 111(9): 1627-1635. doi:10.1016/j.ophtha.2004.02.017
[35] 孟素坤, 付玮, 刘擘, 等. 原发性开角型青光眼患者5年视野缺损进展情况及相关因素[J]. 眼科学报, 2021, 36(6): 426-432. doi:10.3978/j.issn.1000-4432.2021.06.12 MENG Sukun, FU Wei, LIU Bo, et al. Progression and influencing factors of 5-year visual field damage in patients with primary open-angle glaucoma[J]. Eye Science, 2021, 36(6): 426-432. doi:10.3978/j.issn.1000-4432.2021.06.12
[36] Song BJ, Aiello LP, Pasquale LR. Presence and risk factors for Glaucoma in patients with diabetes[J]. Curr Diab Rep, 2016, 16(12): 124. doi:10.1007/s11892-016-0815-6
[37] Sohn EH, van Dijk HW, Jiao CH, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus[J]. Proc Natl Acad Sci USA, 2016, 113(19): E2655-E2664. doi:10.1073/pnas.1522014113
[38] Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy[J]. Can J Ophthalmol, 2009, 44(4): 417-422. doi:10.3129/i09-112
[39] Sugimoto M, Sasoh M, Ido M, et al. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy[J]. Ophthalmologica, 2005, 219(6): 379-385. doi:10.1159/000088382
[40] Investigators A. The Advanced Glaucoma Intervention Study(AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced Glaucoma[J]. Am J Ophthalmol, 2002, 134(4): 499-512. doi:10.1016/S0002-9394(02)01659-8
[41] O'Brien C, Schwartz B, Takamoto T, et al. Intraocular pressure and the rate of visual field loss in chronic open-angle Glaucoma[J]. Am J Ophthalmol, 1991, 111(4): 491-500. doi:10.1016/S0002-9394(14)72386-4
[42] Popovic V, Sjöstrand J. Long-term outcome following trabeculectomy: II Visual field survival[J]. Acta Ophthalmol(Copenh), 1991, 69(3): 305-309. doi:10.1111/j.1755-3768.1991.tb04819.x
[43] Chen PP, Park RJ. Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma[J]. Ophthalmology, 2000, 107(9): 1688-1692. doi:10.1016/S0161-6420(00)00229-3
[44] Carlsson AM, Chauhan BC, Lee AA, et al. Intraocular pressure and progression of glaucomatous visual field loss[J]. Am J Ophthalmol, 1999, 128(6): 697-701. doi:10.1016/S0002-9394(99)00228-7
[45] Ting JLM, Damji KF, Stiles MC. Ab interno trabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma[J]. J Cataract Refract Surg, 2012, 38(2): 315-323. doi:10.1016/j.jcrs.2011.08.043
[46] Wang QQ, Harasymowycz P. Goniopuncture in the treatment of short-term post-Trabectome intraocular pressure elevation: a retrospective case series study[J]. J Glaucoma, 2013, 22(8): e17-e20. doi:10.1097/IJG.0b013e3182595042
[47] Shoji N, Kasahara M, Iijima A, et al. Short-term evaluation of Trabectome surgery performed on Japanese patients with open-angle glaucoma[J]. Jpn J Ophthalmol, 2016, 60(3): 156-165. doi:10.1007/s10384-016-0433-5
[48] Wecker T, Anton A, Neuburger M, et al. Trabeculotomy opening size and IOP reduction after Trabectome? surgery[J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(8): 1643-1650. doi:10.1007/s00417-017-3683-0
[1] LI Lu, ZHAO Jie, ZHAO Bojun. Research progress on the pathogenesis and treatments of central serous chorioretinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 118-124.
[2] LI Zhilin, ZHENG Zhou, AN Wei. Clinical and survival analysis of primary squamous cell carcinoma of the thyroid 12 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 59-63.
[3] XIAO Fuliang, LIN Yun, PAN Xinliang. A clinical study on prophylactic central lymph node dissection in early cN0 papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 64-71.
[4] LI Aijun, CUI Xiaomei. Current status of comprehensive pathway management atrial fibrillation before cataract surgery: a cross-sectional survey [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 38-44.
[5] ZHANG Lijun, XU Ran, LUO Jifang, LIU Guoqi, HE Qian, LI Wei, JIANG Zhenhua. Factors affecting flap neurosis and other postoperative flap-related complications after free-flap reconstruction of head and neck tumors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 86-90.
[6] LIU Shanshan, HAN Shujing, WANG Xiaoxu, LI Yanhong, NI Xin, ZHANG Jie. Hearing loss in children after bacterial meningitis: a systematic review and meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 48-54.
[7] To describe characteristics and risk factors associated with central serous chorioretinopathy(CSC)in a hospital-based outpatient sample population. MethodsIn this hospital-based cross-sectional study, CSC patients were recruited from the Beijing Friendship Hospital from 01/2019 to 12/2019. All participants underwent a standardized interview. Logistic regression models were used to assess the risk factors associated with CSC. ResultsA total of 23,878 outpatients were recorded during the period 01/2019-12/2019. Of these, 45 patients(0.19%)were diagnosed with CSC, divided in 37 male patients(82.22%)and 8 female patients(17.78%). The patients′ age ranged from 21 to 65(42.3±10.1)years. Three patients(6.67%)presented a bilateral involvement. Of all the patients, 39 were included in the present analysis. Control patients were matched for age and sex at a ratio of 1:1. The presence of CSC was associated with exposure to steroids(OR=5.04, 95% CI:1.11-22.89), sleep time(going to sleep after 12 pm)(OR=4.16, 95% CI:1.33-13.04)),and shift-work(OR=5.74, 95% CI:1.47-22.45).ConclusionsOur data showed that CSC prevalence in the analyzed outpatients was 0.19%. Exposure to steroids, sleep time, and shift-work were factors related with CSC in the observed population.. Prevalence and risk factors of central serous chorioretinopathy in a hospital-based population YANG Xiufen, YOU Ran, MA Xiumei, WANG Kang, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 75-79.
[8] This study was conducted to explore the preoperative risk factors for postoperative adhesion in patients with chronic rhinosinusitis(CRS)undergoing functional endoscopic sinus surgery(FESS), and to construct a risk score model to evaluate their predictive effect. MethodsA retrospective study was conducted on 323 patients with CRS who underwent FESS at our hospital between January 2015 and June 2018. The risk factors for postoperative adhesion were screened using a multivariate logistic regression analysis. The risk score was assigned according to the odds ratio(OR)value, and a receiver operating characteristic(ROC)curve was drawn to evaluate the predictive effect. ResultsPostoperative adhesion occurred in 35 patients(10.8%). The logistic regression results showed that concha bullosa, primary FESS, operative experience less than 10 years, and a history of middle turbinate resection were independent risk factors for postoperative adhesion in FESS. The OR values were 1.12(95% CI: 1.06-1.18), 3.87(95% CI: 2.23-5.51), 3.19(95% CI: 2.07-4.31), and 2.24(95% CI:1.95-2.53), respectively. The risk score model assigned 1 point for vesicular middle turbinate, 4 points for first time FESS, 3 points for operative experience less than 10 years, and 2 points for middle turbinate resection. The ROC curve analysis showed that the area under the curve(AUC)was 0.784(95% CI: 0.672-0.896, P<0.05). When 4 points were selected as the cut-off point, the Jordan index was the largest, with a sensitivity of 75.1% and a specificity of 73.6%. ConclusionThe incidence of postoperative adhesion in 323 patients with CRS who underwent FESS was 10.8%. The risk score model has certain reference value for predicting high-risk postoperative adhesion.. Potential risk factors and evaluation of a predictive risk score model for postoperative adhesion in functional endoscopic sinus surgeryCHEN Dong1, YU Hong2, LI Yang1, HUANG Qiang1, FANG Min1 1. Department of Otolaryngology, Jiangyou Peoples Hospital, Jiangyou 621700, Sichuan, China; 2. Department of Pathology, Jiangyou Peoples Hospital, Jiangyou 621700, Sichuan, ChinaAbstract:Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 87-91.
[9] HAO Wenpei, ZHAI Hualei, SUN Xiaotong, ZHANG Yani, ZHU Yanhui, KONG Qianqian, CHENG Jun, ZHANG Ting. Etiology of repeat keratoplasty and risk factors for failure of corneal grafts [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 134-140.
[10] HUANG He, OUYANG Hui. Risk factors and prognosis of esophageal cancer with hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 82-86.
[11] Yongyao LANG,Yun YANG,Qing LIU,Lindi XU,Ziping LIN. Analysis of influencing factors and observation of therapeutic effects in patients with laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 119-123.
[12] JIANG Xiuying, LI Yuanbin. Clinical analysis of posterior intraocular lens dislocation [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 105-110.
[13] CUI Le, GUAN Kai, LI Lisha, LI Junda, WANG Zixi, XU Yingyang, WANG Lianglu, YIN Jia. Analysis of prevalence and related risk factors of bee venom in bee research population [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(1): 63-66.
[14] SHEN Ling, LIN Zongtong, LIN Xing, YANG Zhongjie. Risk factors associated with obstructive sleep apnea-hypopnea syndrome in children: a retrospective case-control study [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 25-29.
[15] . Efficacy and safety of EX-PRESS implanation versus trabeculectomy for open-angle glaucoma: a meta-analysis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 104-111.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd